| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coya Therapeutics, Inc. (COYA) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. COYA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Garren Hideki71 | Director | Buy | 2,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Jan 3, 2023 | Lee Ann | Director | Buy | 10,000 | $0.00 | - | New | -12.9% | +48.2% |